Ephrata Cancer Center — Ephrata, Pennsylvania

Ephrata Cancer Center is a clinical research site located in Ephrata, Pennsylvania, United States 17522.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Ephrata Cancer Center has participated in 125 clinical trials with 86 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Plasma Cell Myeloma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ephrata Cancer Center?

Ephrata Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ephrata Cancer Center conducted?

Ephrata Cancer Center has 125 clinical trials on record, with 86 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Plasma Cell Myeloma.

Is Ephrata Cancer Center accredited by Crixeo Health?

Ephrata Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ephrata Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.